Search for: "Medical & Chemical Research v. Dow*"
Results 1 - 20
of 157
Sorted by Relevance
|
Sort by Date
3 Apr 2007, 12:47 am
The Dow Chemical Co., 701 N.W.2d 684 (Mich. 2005).3. [read post]
22 Jun 2012, 11:41 am
See Johnson v. [read post]
24 Oct 2014, 9:46 am
Existing literature: IP rights without disclosure may reduce follow-on academic research/commercial development; with disclosure IP rights may reduce downstream innovation in computers, electronics, medical instruments, but not in drugs, chemicals, or mechanical technologies. [read post]
15 Apr 2009, 4:44 am
Our research indicates that at present, the law is all over the lot. [read post]
24 Sep 2014, 4:53 pm
Sometimes the actual chemicals involved in a medication are not very expensive and the manufacture/distribution process not complex.The fact... [read post]
11 Nov 2018, 7:18 am
Further research is needed to elucidate these relationships. [read post]
24 Nov 2019, 1:26 pm
Athena Diagnostics, Inc. v. [read post]
25 Aug 2014, 9:35 am
Pritchard v. [read post]
3 May 2021, 9:08 pm
Supreme Court decision in Bostock v. [read post]
19 Oct 2011, 11:27 am
Co. v. [read post]
13 Apr 2024, 3:33 pm
After feedback from the public and the Yale researchers, the group submitted a final protocol in April 1994. [read post]
17 Jul 2017, 3:18 pm
Millennium Pharma v. [read post]
20 Mar 2012, 1:38 pm
The ruling came in the case of Mayo Collaborative Services, et al., v. [read post]
22 Apr 2011, 3:40 am
Smith has published dozens of peer reviewed articles in scientific journals, describing his research into how benzene causes disease, including AML. [read post]
15 Nov 2013, 11:34 am
After researching qui tam false claims actions, [relator] placed an ad in a [local] newspaper soliciting minor Medicaid patients who had received certain medications.Id. at *1. [read post]
13 May 2009, 8:00 pm
Amgen Inc. v. [read post]
30 Nov 2012, 1:24 pm
Allen v. [read post]
26 Aug 2016, 2:45 pm
Research finds that it takes around 14 years from a chemical's emergence to the height of public concern about its effects. [read post]
15 Aug 2016, 8:13 am
Fortunately the pharmaceutical industry helps alleviate this issue with generic drugs, which are chemically almost identical and are marketed after the patent on the name-brand medication expires. [read post]
23 Jan 2013, 1:02 am
We note, however, that DHHS’ recommendation explained that “[t]he opportunity for scientists to conduct clinical research with marijuana exists under the [D]HHS policy supporting clinical research with botanical marijuana. [read post]
